Invida is a specialty pharma company formed by a joint venture between Quintiles, Temasek and Zuellig. We focus on the Asia Pacific region and have a significant presence across 13 countries in the region, with headquarters in Singapore. Invida specializes in the development and commercialization of pharmaceuticals in these markets. We enjoy multiple partnerships with multinational pharmaceutical companies based in Europe, US and Japan as well as some more local players.